NCT Number: NCT00308295
A Pilot Study of Fish Oil Supplementation in Hemodialysis Patients
The main goal of this study is to determine whether the American Heart Association-recommended fish oil dose is efficacious, safe, and tolerable in hemodialysis patients. The secondary objective is to test the effects of fish oil supplementation on inflammatory and cardiovascular markers.
Looking for future studies?
Notify MeKey information
Age range
18 year–82 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Primary location
Indiana University Nephrology Clinics, Indianapolis, Indiana, United States
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Exclusion criteria
- Age <18
- Pregnant individuals
- Fish oil or omega-3 supplementation in past 6 months
- Fish, corn, soybean, gelatin, or vanilla allergies
- Currently enrolled in a dietary or investigational drug study
- Life expectancy < 3 months
- Ongoing active illness requiring hospitalization
- Malabsorption syndromes
- Chronic heparin or coumadin anticoagulation (??)
- Active bleeding issues
Treatment and study plan
matched placebo capsules
DrugPrimary outcomes
-
To determine whether AHA-recommended fish oil therapy beneficially affects the pro-inflammatory/anti-inflammatory blood fatty acid balance
Secondary outcomes
-
To test the safety and tolerability of fish oil therapy in hemodialysis patients
-
To measure the effects of fish oil treatment on cardiovascular and inflammatory risk factors
Sponsors and collaborators
Lead sponsor
Indiana University
Other
Registry information
Important dates
- Study start
- 2006
- Study completion
- 2006
- First posted
- Mar 29, 2006
- Registry last updated
- Oct 16, 2007
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.